Workflow
特一药业:盐酸多西环素片通过一致性评价
002728TY PHAR.(002728) 证券时报网·2025-02-27 08:15

Core Viewpoint - The company Teva Pharmaceutical Industries Ltd. has announced that its Doxycycline Hydrochloride Tablets have passed the consistency evaluation for chemical generic drug quality and efficacy [1] Group 1: Product Details - The Doxycycline Hydrochloride Tablets consist of two specifications: 0.05g and 0.1g, with the 0.05g specification being the first to pass the consistency evaluation and the 0.1g specification being the second [1] - Doxycycline Hydrochloride Tablets are primarily used for treating upper respiratory infections, tonsillitis, biliary infections, lymphadenitis, cellulitis, and chronic bronchitis in the elderly caused by sensitive Gram-positive cocci and Gram-negative bacilli [1]